Literature DB >> 7196256

Argon laser photocoagulation of symptomatic flap tears and retinal breaks of fellow eyes.

A Pollak, M Oliver.   

Abstract

A series of 95 eyes (93 patients) with retinal breaks, high-risk candidates for rhegmatogenous retinal detachment, were treated prophylactically with argon laser photocoagulation (ALP). Group A comprised 74 eyes with flap symptomatic tears. In 28 of these (subgroup A (1)) the size of the tear was smaller than 1 disc diameter and greater than 1/3 disc diameter. In 46 eyes (subgroup A (2)) the size of the tear was at least 1 disc diameter but not greater than 3 disc diameters. Group B comprised 21 fellow eyes with 34 retinal breaks in patients who had retinal detachment in the other eye. One patient of subgroup A (1) developed a rhegmatogenous retinal detachment 6 days after ALP treatment. One patient of group B developed a retinal detachment after cataract extraction. This detachment was unrelated to the previously treated retinal break. In the series of group A the mean follow-up period was 27.8 months. From previously reported follow-up data it is probable that at least in the case of flap symptomatic tears our results can be considered conclusive. There were no complications related to the prophylactic treatment of dangerous retinal breaks with ALP. This form of treatment is accurate, easy to use, and comfortable for the patient. ALP would appear to be superior to xenon arc photocoagulation and cryopexy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196256      PMCID: PMC1039552          DOI: 10.1136/bjo.65.7.469

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Limits and hazards of photocoagulation.

Authors:  P A CIBIS
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1962 Jan-Feb

2.  Preventive treatment of retinal detachment by means of light coagulation.

Authors:  B H COLYEAR; D K PISCHEL
Journal:  Trans Pac Coast Otoophthalmol Soc Annu Meet       Date:  1960

3.  Xenon photocoagulation vs. cryotherapy in the prevention of retinal detachment.

Authors:  I Boniuk; E Okun; G P Johnston; N Arribas
Journal:  Mod Probl Ophthalmol       Date:  1974

4.  Chorioretinal lesions predisposing to retinal detachment.

Authors:  S W Hyams; E Meir; M Ivry; D Krakowski; S Barkai; E Jedwab; E Neumann
Journal:  Am J Ophthalmol       Date:  1974-09       Impact factor: 5.258

5.  Long-term follow-up of treated retinal breaks.

Authors:  D M Robertson; E W Norton
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

6.  Exudative retinal detachments following scleral buckling with cryotherapy.

Authors:  T M Aaberg; G J Pawlowski
Journal:  Am J Ophthalmol       Date:  1972-08       Impact factor: 5.258

7.  The fate of the fellow eye in retinal detachment.

Authors:  S Merin; V Feiler; S Hyams; M Ivry; D Krakowski; L Landau; B Maythar; I C Michaelson; J Scharf; A Schul; I Ser
Journal:  Am J Ophthalmol       Date:  1971-02       Impact factor: 5.258

Review 8.  Vitreous base classification of retinal tears: clinical application.

Authors:  J Sigelman
Journal:  Surv Ophthalmol       Date:  1980 Sep-Oct       Impact factor: 6.048

9.  Lattice degeneration of the retina.

Authors:  N E Byer
Journal:  Surv Ophthalmol       Date:  1979 Jan-Feb       Impact factor: 6.048

10.  The prevention of retinal detachment.

Authors:  C B Mortimer
Journal:  Can J Ophthalmol       Date:  1966-07       Impact factor: 1.882

View more
  3 in total

Review 1.  Management of retinal detachment: a guide for non-ophthalmologists.

Authors:  Hyong Kwon Kang; A J Luff
Journal:  BMJ       Date:  2008-05-31

Review 2.  [Secondary diseases in high myopia].

Authors:  F Ziemssen; W Lagrèze; B Voykov
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

3.  Treated retinal breaks: clinical course and outcomes.

Authors:  Robert B Garoon; William E Smiddy; Harry W Flynn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-09       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.